The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease

New England Journal of Medicine

Volumn 336, Issue 11, 1997, Pages 747-754

  Alter, Harvey J ^a,c   Nakatsuji, Yoshiyuki ^a   Melpolder, Jacqueline ^a   Wages, John ^b   Wesley, Robert ^a   Shih, J Wai Kuo ^a   Kim, Jungsuh P ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Genelabs Incorporated   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATITIS C; HEPATITIS VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS TRANSMISSION;

ACUTE DISEASE; ALANINE TRANSAMINASE; BLOOD DONORS; BLOOD TRANSFUSION; FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; PREVALENCE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 0031042269     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199703133361102     Document Type: Article

References (14)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
2. Kou G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362-4.
3. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
4. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1989; 327:1899-905.
5. Alter HJ, Jett BW, Polito AJ, et al. Analysis of the role of hepatitis C virus in transfusion-associated hepatitis. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:396-402.
6. Linnen J, Wages J Jr, Zhang-Keck Z-Y, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
7. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334:1485-90.
8. Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-95.
9. Alter HJ, Sanchez-Pescador R, Urdea MS, et al. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 1995;2:121-32.
10. Tsarev SA, Tsarev TS, Emerson SU, et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis 1993;168:369-78.
11. Armitage P. Statistical methods in medical research. New York: John Wiley, 1971:135-8.
12. Kotz S, Johnson NL, eds. Encyclopedia of statistical sciences. New York: John Wiley, 1983:709-10.
13. Bickel PJ, Doksum KA. Mathematical statistics: basic ideas and selected topics. San Francisco: Holden-Day, 1977:162.
14. Weiner AJ, Truett MA, Rosenblatt J, et al. HCV testing in low-risk population. Lancet 1990;336:695.